Morana  Jovan-Embiricos net worth and biography

Morana Jovan-Embiricos Biography and Net Worth

Director of AlloVir
In 2003, Dr. Jovan co-founded F2 Ventures, a biotech venture capital platform and has since served as its Managing Partner. Prior to joining F2 Ventures, Dr. Jovan was a partner at MPM Capital. Dr. Jovan currently serves on the boards of directors of Damon Runyon Cancer Center Research Foundation, TriNetX, Inc. and Cullinan Oncology. Dr. Jovan received her Ph.D. in biophysical chemistry from the University of Cambridge and was a post-doctoral fellow at Harvard University.

How do I contact Morana Jovan-Embiricos?

The corporate mailing address for Dr. Jovan-Embiricos and other AlloVir executives is 139 MAIN STREET SUITE 500, CAMBRIDGE MA, 02142. AlloVir can also be reached via phone at 617-433-2605 and via email at ir@allovir.com. Learn More on Morana Jovan-Embiricos' contact information.

Has Morana Jovan-Embiricos been buying or selling shares of AlloVir?

Morana Jovan-Embiricos has not been actively trading shares of AlloVir during the last ninety days. Most recently, Morana Jovan-Embiricos sold 165 shares of the business's stock in a transaction on Tuesday, November 9th. The shares were sold at an average price of $570.17, for a transaction totalling $94,078.05. Learn More on Morana Jovan-Embiricos' trading history.

Who are AlloVir's active insiders?

AlloVir's insider roster includes Ercem Atillasoy (Insider), Jeffrey Bornstein (Director), Brett Hagen (CAO), David Hallal (Director), Morana Jovan-Embiricos (Director), Ann Leen (Insider), Agustin Melian (Insider), Jeroen Van Beek (Insider), Juan Vera (Director), and John Wilson (Director). Learn More on AlloVir's active insiders.

Are insiders buying or selling shares of AlloVir?

In the last year, insiders at the sold shares 47 times. They sold a total of 5,455 shares worth more than $89,737.40. The most recent insider tranaction occured on January, 23rd when General Counsel Edward Miller sold 52 shares worth more than $494.00. Insiders at AlloVir own 32.1% of the company. Learn More about insider trades at AlloVir.

Information on this page was last updated on 1/23/2025.

Morana Jovan-Embiricos Insider Trading History at AlloVir

See Full Table

Morana Jovan-Embiricos Buying and Selling Activity at AlloVir

This chart shows Morana Jovan-Embiricos's buying and selling at AlloVir by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1$0Total Insider BuyingTotal Insider Selling

AlloVir Company Overview

AlloVir logo
AlloVir, Inc. engages in the research, development and commercialization of off-the-shelf VST therapies to prevent and treat severe viral-associated diseases. It develops novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems. The firm's technology platforms deliver commercially scalable solutions by leveraging off-the-shelf, allogeneic, multi-virus specific T-cells targeting devastating viral pathogens for immunocompromised patients under viral attack. The company was founded by Malcolm K. Brenner, Juan F. Vera, Helen E. Heslop, Cliona M. Rooney, John R. Wilson, and Ann M. Leen in August 2013 and is headquartered in Waltham, MA.
Read More

Today's Range

Now: $10.05
Low: $9.95
High: $10.10

50 Day Range

MA: $10.29
Low: $8.77
High: $12.22

2 Week Range

Now: $10.05
Low: $7.96
High: $24.15

Volume

6,842 shs

Average Volume

44,465 shs

Market Capitalization

$50.55 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.65